1 min read
Add as a preferred source on GoogleHims & Hers Health Narrows 2026 Guidance After Q3 Results
The telehealth provider projects full-year 2026 revenue of $3.13 billion to $3.15 billion and narrowed its EBITDA guidance.
Hims & Hers Health reported third-quarter results that missed expectations Monday, Nov. 9, and narrowed its 2026 guidance, setting a full-year revenue forecast of $3.13 billion to $3.15 billion.
The telehealth provider also narrowed its EBITDA guidance for 2026. Its shares were at $22.12, down 14.92%, at 9:41 a.m. ET (14:41 UTC) Tuesday, Nov. 10.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.